EMA/CO REGIMEN IN HIGH-RISK GESTATIONAL TROPHOBLASTIC TUMOR (GTT)

被引:91
作者
BOLIS, G
BONAZZI, C
LANDONI, F
MANGILI, G
VERGADORO, F
ZANABONI, F
MANGIONI, C
机构
[1] UNIV MILAN,DEPT OBSTET & GYNECOL 5,DIDACT SECT MONZA,I-20129 MILAN,ITALY
[2] UNIV MILAN,DEPT OBSTET & GYNECOL 1,I-20129 MILAN,ITALY
关键词
D O I
10.1016/S0090-8258(88)80029-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:439 / 444
页数:6
相关论文
共 15 条
[1]  
BAGSHAWE KD, 1976, CANCER, V38, P1373, DOI 10.1002/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO
[2]  
2-E
[3]  
BAGSHAWE KD, 1976, ANN ACADEMY MEDICINE, V5, P273
[4]  
BEGENT RHJ, 1982, SEMIN ONCOL, V9, P198
[5]  
BERKOWITZ RS, 1979, OBSTET GYNECOL, V54, P725
[6]   MODIFIED TRIPLE CHEMOTHERAPY IN THE MANAGEMENT OF HIGH-RISK METASTATIC GESTATIONAL TROPHOBLASTIC TUMORS [J].
BERKOWITZ, RS ;
GOLDSTEIN, DP ;
BERNSTEIN, MR .
GYNECOLOGIC ONCOLOGY, 1984, 19 (02) :173-181
[7]  
LURAIN JR, 1982, OBSTET GYNECOL, V60, P354
[8]   ANTI-TUMOR ACTIVITY OF THE EPIPODOPHYLLIN DERIVATIVE VP16-213 (ETOPOSIDE-NSC-141540) IN GESTATIONAL CHORIOCARCINOMA [J].
NEWLANDS, ES ;
BAGSHAWE, KD .
EUROPEAN JOURNAL OF CANCER, 1980, 16 (03) :401-405
[9]   DEVELOPMENTS IN CHEMOTHERAPY FOR MEDIUM-RISK AND HIGH-RISK PATIENTS WITH GESTATIONAL TROPHOBLASTIC TUMORS (1979-1984) [J].
NEWLANDS, ES ;
BAGSHAWE, KD ;
BEGENT, RHJ ;
RUSTIN, GJS ;
HOLDEN, L ;
DENT, J .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1986, 93 (01) :63-69
[10]   INTENSIVE INPATIENT THERAPY AND SURVIVAL IN GESTATIONAL TROPHOBLASTIC DISEASE [J].
WEED, JC ;
JELOVSEK, FR ;
TYREY, L ;
HAMMOND, CB .
GYNECOLOGIC ONCOLOGY, 1983, 15 (03) :363-369